Selected Publications

Freeman, TL, Andreaou, C, Sebra, RP, Beaumont, KG, and TH Swartz. 2021. Single-Cell Characterization of Calcium Influx and HIV-1 Infection Using a Multiparameter Optofluidic Platform. Journal of Visualized Experimentation. PMID: 34096922.





Soare, AY, Freeman, TL, Min, AK, Malik, HS, Osota, EO, and TH Swartz. 2021. P2RX7 at the host-pathogen interface of infectious diseases. Micro and Molec Biol Rev 85 (1) e00055-20;






Del Valle, DM, Kim-Schulze, SK, Hsin-Hui, H, Beckmann, ND, Nirenberg, S, Wang, B, Lavin, Y, Swartz, TH, Madduri, D, Stock, A, Marron, T, Xie, H, Patel, MK, van Oekelen, O, Rahman, A, Kovatch, P, Aberg, H, Schadt, E, Jagannath, S, Mazumdar, M, Charney, A, Firpo-Betancourt, A, Mendu, DR, Jhang, J, Reich, D, Sigel, K, Cordon-Cardo, C, Feldmann, M, Parekh, S, Merad, M, and S Gnjatic. An inflammatory cytokine signature helps predict COVID-19 severity and death. Nature Medicine. PMC7274243.





Sigel, KM, Swartz, TH, Golden, E, Paranipe, I, Somani, S, Richter, F, De Freitas, JK, Miotto, R, Zhao, S, Polak, P, Mutetwa, T, Factor, S, Mehandru, S, Mullen, M, Cossarini, F, Bottinger, E, Fayad, Z, Merad, M, Ghjatic, S, Aberg, J, Charney, A, Nadkarni, G, Glicksberg, BS. 2020. Covid-19 and People with HIV Infection: Outcomes for Hospitalized Patients in New York City. Clinical Infectious Diseases. Clinical Infectious Diseases, ciaa880, PMC7337691.




Freeman, TL and TH Swartz. 2020. Purinergic Receptors: Elucidating the Role of These Immune Mediators in HIV-1 Fusion. Viruses; 12, 290.







Soare, AY, Malik, HS, Durham, ND, Freeman, TL, Alvarez, RA, Patel, F, Satija, N, Upadhyay, C, Hioe, CE, Chen, BK, and TH Swartz. 2020. P2X1 selective antagonists block HIV-1 productive infection through inhibition of envelope-dependent fusion. J Virol; 94, 6.






Soare, AY, Durham, ND, Patel, F, Satija, N, Gopal, R, Tweel, B, Hoffman, KW, Upadhyay, C, O’Brien, M, Bhardwaj, N, Lim, JK, Hioe, CE, Chen, BK, and TH Swartz. 2019. P2X antagonists inhibit HIV-1 productive infection and inflammatory cytokines IL-10 and IL-1β in a human tonsil explant model. J Virol. e01186-18. PMC6288349.






Arens, Y, Gaisa, M, Goldstone, S, Liu, Y, Wisnivesky, J, Sigel, C, Swartz, TH, Sigel, K. 2019. Risk of invasive anal cancer in HIV-1 infected patients with high-grade anal dysplasia: a population-based cohort study. Dis Colon Rectum. PMC6613994.

Liu, STH, Bailey, M, Zhen, A, Saunders-Hao, P, Bassily-Marcus, A, Harding, M, Rana, M, Kohli-Seth, R, Patel, G, Huprikar, S, and TH Swartz. 2018. An electronic antimicrobial stewardship intervention reduces inappropriate parenteral antibiotic therapy. Infection control and hospital epidemiology 39(11), p. 1396-1397.

Esposito, AM, Soare, AY, Patel, F, Satija, F, Chen, BK, and TH Swartz. 2018. A high throughput Cre-lox activated viral membrane fusion assay to identify inhibitors of HIV-1 viral membrane fusion. Journal of Visualized Experimentation. J Vis Exp. 183, e58074, PMC6126790.

Liu Y, Gaisa M, Wang X, Swartz TH, Arens Y, Dresser K, Sigel C, Sigel K. 2018. Immune Microenvironments of Anal Cancer Precursors Differ by HIV-serostatus, Affecting Ablation Outcomes. Journal of Infectious Diseases. J Infect Dis. Feb 14;217(5):703-709. PMC5853940.

Esposito, A, Swartz, TH, and BK Chen. 2016. A high throughput cre-lox activated HIV membrane fusion assay identifies pharmacological inhibitors of viral entry. Virology. 490:6-16. PMC5019951.

Yu, J, Wilkins, J, Ding, S, Swartz, TH, et al. 2015. IFITM Proteins Restrict HIV-1 Infection by Antagonizing the Envelope Glycoprotein. Cell Rep. 13(1):145-56. PMC4602366.

Swartz, TH, Esposito, AM, Durham, ND, Hartmann, BM, and BK Chen. 2014. P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection. J. Virol. PMC4178786.